2-(hydroxymethyl)anthraquinone has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bokser, L; Halmos, G; Janáky, T; Juhász, A; Milovanovic, S; Pinski, J; Redding, TW; Rékási, Z; Serfözö, P; Srkalovic, G | 1 |
1 other study(ies) available for 2-(hydroxymethyl)anthraquinone and Breast Neoplasms
Article | Year |
---|---|
Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
Topics: Amino Acid Sequence; Animals; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Cell Membrane; Cell Survival; Cisplatin; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Melphalan; Methotrexate; Molecular Sequence Data; Oligopeptides; Orchiectomy; Pituitary Gland; Prostatic Neoplasms; Rats; Receptors, LHRH; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |